Morgan Lewis

Life Sciences Related News

For More Information

Read the Brochure

Life Sciences and Healthcare

New Resource

Healthcare Policy and Reform Resource Center

Life Sciences Deskbook

Compliance Resources

New Resource: Health Industry Transparency Compliance Resource Center

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Honors

LMG Life Sciences 2012 – Highly Recommended for Licensing and Collaboration, and for White Collar and Government Investigations. Recommended for FDA – Pharmaceuticals; Healthcare: Pricing and Reimbursement; Patent Prosecution; General Patent Litigation; Corporate; and Competition and Antitrust

PLCCross-border Quarterly 2012 Life Sciences Legal Market Review

  • Life Sciences Regulatory Super League - Ranked 8th among law firms worldwide

PLCCross-border Life Sciences Handbook 2011/12

  • U.S.:
    • Commercial and Partnering - Highly Recommended
    • Competition/Antitrust - Highly Recommended
    • Corporate - Recommended
    • Government Enforcement and Investigations - Highly Recommended
    • Regulatory - Recommended
    • Regulatory (Medical Devices) - Recommended
  • England: Regulatory - Recommended
  • Japan: Corporate and Commercial - Recommended

Chambers Global 2012: Global Life Sciences - Recommended - Band 3

Chambers USA 2012: National for Life Sciences - Band 3; Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory - Band 3

UK Legal 500 2010: London: Pharmaceuticals and Biotechnology

Best Lawyers in America 2011: Biotechnology and Healthcare Law Named

BioPharm Insight 2012

  • Ranked 3rd - Global League Table of Legal Advisers to Biotech and Pharma Licensing Agreements - Based upon Value
  • Ranked 4th - Global League Table of Legal Advisers to Biotech and Pharma Licensing Agreements - Based upon Volume
  • Ranked 10th - Legal Advisors to Biotech and Pharma Licensing Agreements: North America - Based upon Value
  • Ranked 5th - Legal Advisors to Biotech and Pharma Licensing Agreements: North America - Based upon Volume
  • Ranked 2nd - Legal Advisors to Biotech and Pharma Licensing Agreements: Europe - Based upon Value
  • Ranked 3rd - Legal Advisors to Biotech and Pharma Licensing Agreements: Europe - Based upon Volume
  • Ranked 2nd - Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific - Based upon Value
  • Ranked 3rd - Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific - Based upon Volume

U.S. News & World Report/Best Lawyers 2010: Ranked Tier 1 National Practice - Biotechnology

Clients

16 of the top 20 pharmaceutical companies

7 of the top 20 biotechnology companies

9 of the top 20 medical device companies

Practice Highlights

Related Events

Related News

05/15/13 Pharma Cos. Smell Victory In Push For Drug-Tracking System, Law360
Life Sciences partner Stephen Paul Mahinka is quoted.
04/30/13 Top 25 Portfolio Managers/Patent Prosecutors, Daily Journal
Jeffry S. Mann is listed as one of the "Top 25 Portfolio Managers/Patent Prosecutors" for 2013 by the Daily Journal.
04/11/13 Morgan Lewis Advises MEI Pharma on $15.2 Million Registered Offering of Common Stock
Morgan Lewis served as legal adviser to MEI Pharma, Inc. on registered offering of common stock.
View all news

Related Publications

05/08/13 HHS OIG Issues Report on Hospice General Inpatient Care Billing
Report makes no formal recommendations, but OIG notes that lengths of stay and frequency of general inpatient care are issues requiring further scrutiny.
04/29/13 CMS Aims to Grease the Reporting Wheels for Medicare Fraud and Abuse
Proposed rule would substantially increase rewards for fraud tips and enhance billing revocation authority.
04/17/13 HHS OIG Issues Revised Self-Disclosure Protocol
OIG touts substantial benefits of disclosing, provides greater detail for different types of disclosures, and captures 15 years of OIG Self-Disclosure Protocol experience.
View all publications
52 news articles found
page 1 of 3
May 15, 2013 - Pharma Cos. Smell Victory In Push For Drug-Tracking System, Law360

Life Sciences partner Stephen Paul Mahinka is quoted.

Apr 30, 2013 - Top 25 Portfolio Managers/Patent Prosecutors, Daily Journal

Jeffry S. Mann is listed as one of the "Top 25 Portfolio Managers/Patent Prosecutors" for 2013 by the Daily Journal.

Apr 11, 2013 - Morgan Lewis Advises MEI Pharma on $15.2 Million Registered Offering of Common Stock

Morgan Lewis served as legal adviser to MEI Pharma, Inc. on registered offering of common stock.

Mar 29, 2013 - 6 Health Policies A Gridlocked Congress Can Get Behind, Law360

Life Sciences partner Stephen Paul Mahinka is quoted.

Mar 25, 2013 - Latest FDA User Fee Bill Unlikely To Include Major Reforms, Law360

Life Sciences partner Stephen Paul Mahinka is quoted.

Jan 28, 2013 - Morgan Lewis Strengthens Business and Finance Practice in Boston with Private Equity Transactions Partner

Morgan Lewis announces that Mark B. Stein has joined the firm in its Business and Finance Practice, resident in the firm's Boston office.

Jan 07, 2013 - Life Sciences Regulation To Watch In 2013, Law360

FDA & Healthcare partner Kathleen M. Sanzo is quoted.

Jan 07, 2013 - IP Cases To Watch In 2013, Law360

Litigation partner Rick L. Rambo is quoted.

Dec 10, 2012 - Life Sciences MVP: Morgan Lewis' Randall Sunberg, Law360

Morgan Lewis partner Randall Sunberg is named one of Law360's Life Sciences MVPs.

Nov 15, 2012 - DOJ, SEC Release Resource Guide Detailing Enforcement Approach, Priorities Under FCPA, BNA's Health Care Daily Report

FDA & Healthcare partner Katie McDermott is quoted.

Sep 12, 2012 - Morgan Lewis Lures Food And Drug Team From K&L Gates

Morgan Lewis's addition of a five-partner food, drug and medical device regulatory team to its Washington office is discussed.

Sep 05, 2012 - Morgan Lewis Grows FDA & Healthcare Practice with Five-Partner Food and Drug Team

Morgan Lewis announces that a team of five well-recognized FDA regulatory lawyers have joined the firm as partners in its FDA and Healthcare Practice, resident in Washington, D.C.

Jun 19, 2012 - Drugmakers Find Much To Love In Final FDA Reform Bill, Law360

Life Sciences partner Stephen Paul Mahinka is quoted.

Jun 11, 2012 - Center for Biologics Evaluation and Research, FDLI Update

Life Sciences partner Stephen Paul Mahinka is quoted.

Jun 06, 2012 - Q&A With Morgan Lewis' Steve Mahinka, Law360

Life Sciences Partner Steve Mahinka is interviewed for Law360's Q&A series.

May 04, 2012 - Regulatory Policy: CBER Importance Boosted With Attention To Biologic Drugs, Biosimilars, Speakers Say

Life Sciences and Healthcare partner Stephen Paul Mahinka is quoted.

Apr 25, 2012 - Q&A With Morgan Lewis' Randall Sunberg, Law360

Business and Finance partner Randall Sunberg is interviewed as part of Law360's Q&A series.

Apr 05, 2012 - Biosimilars Naming and Labeling: An FDLI Dialogue, Update Magazine

Life Sciences and Healthcare partner Stephen Paul Mahinka is quoted.

Mar 23, 2012 - Morgan Lewis Advises GlaxoSmithKline on Investment in New €150m Index Ventures Life Sciences Fund

Morgan Lewis served as legal advisor to GlaxoSmithKline on its investment in an Index Ventures fund solely dedicated to making investments in the life sciences sector.

Mar 12, 2012 - Licensing Dispute Inspired Yelling and Screaming: Plaintiffs Defeated First-Flight Defense Team in Dispute Over Hypertension Pharmaceutical, The National Law Journal

Christopher Banks, Rollin Chippey II, and Benjamin Smith discuss their win in a recent pharmaceutical dispute.

Jan 04, 2012 - Former VP and Deputy GC of Cephalon Joins Morgan Lewis

Morgan Lewis today announces that Steven A. Reed has joined the firm as a partner in its Litigation Practice, resident in Philadelphia.

Jan 20, 2011 - Morgan Lewis Advises Perrigo on $540 Million Acquisition of Paddock Assets

Morgan Lewis advised Perrigo Company, a global healthcare products supplier, on its acquisition of nearly all of the assets of Paddock Laboratories, Inc. for $540 million in cash.

Oct 29, 2010 - Morgan Lewis Advises Safeguard Scientifics on $587 Million Sale of Clarient to GE Healthcare

In a transaction valued at $587 million, Clarient, Inc. has agreed to be acquired by GE Healthcare.

Oct 28, 2010 - Morgan Lewis Advises BMP Sunstone on Acquisition by Sanofi-Aventis

BMP Sunstone and sanofi-aventis announced that they have entered into a definitive agreement where sanofi-aventis will acquire all outstanding shares of BMP Sunstone at $10 per share, or approximately $520.6 million.

Aug 19, 2010 - Morgan Lewis Ranks Among Top Life Sciences M&A Firms in Second Quarter

Morgan Lewis placed highly among global law firms in BioPharm Insight’s second quarter licensing and mergers and acquisitions rankings.

page 1 of 3